A new study demonstrates that adding electric field therapy to chemotherapy can improve survival for those with glioblastoma, which is an aggressive brain cancer with few effective treatment options.
Researchers found that individuals with glioblastoma who were treated with tumor-treating fields (TTFields) — a form of electric field therapy — plus chemotherapy lived longer than patients who were treated with chemotherapy alone.
The combination of TTFields and chemotherapy also increased the number of months that the patients lived without their disease progressing.
